Contact:

 

Dacia Morris
212-543-5421
morrisd@pi.cpmc.columbia.edu

 

FOR IMMEDIATE RELEASE

LATEST RESEARCH SHOWS MARIJUANA USE MAY BE A
GATEWAY TO RELAPSE

 

New York, NY—August 5, 2005—Results of a study released in this month’s American Journal of Psychiatry suggest that using cannabis or marijuana after treatment for cocaine or alcohol dependence is a significant predictor of relapse to previous drug/alcohol use. The study, which was carried out by researchers at the New York State Psychiatric Institute at Columbia University Medical Center, is believed to be “the first such study to address the effects of cannabis use on post-discharge outcome of inpatients treated for alcohol, cocaine, and/or heroin.”

While marijuana has long been considered a gateway drug, its use implicated in the subsequent graduation to the abuse of more addictive drugs like cocaine, this study now suggests marijuana may be a gateway drug to relapse.

Dr. Efrat Aharonovich, the lead investigator, and colleagues interviewed 250 adults who had received treatment for substance abuse in an inpatient setting. At the beginning of the study, 75% of the participants met the criteria for alcohol dependence, 58% met the criteria for cocaine dependence and 20% met the criteria for heroin dependence. Fifteen percent of the participants were marijuana dependent. (Dependency suggests an obsessive preoccupation in addition to chemical activity in the brain.)

Follow up interviews were conducted at six, 12 and 18 months following the initial meeting. The authors were particularly interested in determining (1) participants’ use of substances after discharge, (2) the number of participants who remained in remission (determined to be at least 26 weeks without substance use) and (3) the number of participants who relapsed, that is used marijuana one or more weeks after remission.

“We found that not only was marijuana use in those who relapsed five times greater than those who did not, but low remission rates in participants were associated with high rates of marijuana use,” said Dr. Aharonovich, a psychologist and research scientist. The findings related to heroin were far less significant, with marijuana showing no effect on relapse to the drug. “I believe our study indicates that marijuana use is not quite as harmless as one would like to think,” Dr. Aharanovich added.

While the authors concur that more studies need to be done, these findings are important in their potential implementation in the care of recovering substance abusers. In addition, Dr. Aharonovich and her colleagues point to the increased potency of marijuana and its increased abuse and dependence as even greater incentive for mental health providers to consider its role in treatment outcome.

Go Back to News Releases